Consistent with clinical trial data, a two-dose regimen prevented 90 percent of infections by two weeks after the second shot. One dose prevented 80 percent of infections by two weeks after vaccination.
Tag: BioNTech SE
Hong Kong Suspends Pfizer-BioNTech Vaccine Use Over Packaging Defects
Officials said they had found no health risks, but the move deals a blow to the Chinese city’s already troubled inoculation campaign.
Rich Countries Signed Away a Chance to Vaccinate the World
Despite warnings, American and European officials gave up leverage that could have guaranteed access for billions of people. That risks prolonging the pandemic.
Hungary Pays $36 Per Dose for Chinese Vaccine
The European nation has agreed to pay $36 per dose of the Sinopharm vaccine, according to contracts put online by a Hungarian official.
Germans Clamor for Covid Vaccines, but Shun AstraZeneca’s Offering
Hundreds of thousands of AstraZeneca doses are sitting unopened as many Germans reject the vaccine over fears it is “second-class” compared to the one developed by BioNTech and Pfizer.
Germany, Once a Model, Is Swamped Like Everyone Else by Pandemic’s Second Wave
After winning widespread recognition for its handling of the coronavirus last year, Germany now finds itself struggling with sluggish vaccinations and a frustrated population.
Studies Suggest People Who Had Covid-19 Should Get Single Vaccine Dose
New studies show that one shot of a vaccine can greatly amplify antibody levels in those who have recovered from the coronavirus.
People Who Have Had Covid Should Get Single Vaccine Dose, Studies Suggest
New studies show that one shot of a vaccine can greatly amplify antibody levels in those who have recovered from the coronavirus.
E.U. and U.K. Fight Over Covid Vaccines: ‘Solidarity Is Failing’
As vaccine production falls behind schedule, and the European Union lags in inoculating people, Brussels and London are lobbing threats and accusations at each other.
‘Solidarity Is Failing’: E.U. and U.K. Fight Over Scarce Vaccines
As vaccine production falls behind schedule, and the European Union lags in inoculating people, Brussels and London are lobbing threats and accusations at each other.